Anika Therapeutics, Inc. Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate
Anika Therapeutics, Inc. (ANIK) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate of 1.15% for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-04.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate · last filed 2015-05-04
- Anika Therapeutics, Inc. share-based goods and nonemployee services transaction, valuation method, risk free interest rate for the quarter ending 2015-03-31 was 1.15%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 3 month |
|---|---|
| 2015-03-31 | 1.15% 10-Q · filed 2015-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |